Blog & News

Next 5 Year Round of PCD Research Re-funded

We are delighted to announce that the Genetic Disorders of Mucociliary Clearance Consortium (GDMCC) has been re-funded for another five years (years 15-20) of research on PCD and related disorders. Here is the official announcement from the National Center for Advancing Translational Sciences (NCATS). Link to article: https://ncats.nih.gov/news/releases/2019/rdcrn-funding WHAT’S NEW

Read More

Vertex Announces FDA-Approval of New Triple Drug Compound Effective for the Most Common Mutation in Cystic Fibrosis

Vertex Announces FDA-Approval of New Triple Drug Compound Effective for the Most Common Mutation in Cystic Fibrosis Yesterday, the CF Foundation and Vertex announced that the FDA had approved a triple-drug compound that is designed to be effective for the most common—and most severe—mutation in cystic fibrosis (CF). The new

Read More

PCDF Research Forum #8: Variation in treatment strategies of Pseudomonas in PCD

Variation in treatment strategies for the eradication of Pseudomonas aeruginosa in primary ciliary dyskinesia across European centers Chronic Respiratory Disease Published July 18 2018 Suzanne Crowley, Mathias Gelderman Holgersen, Kim Gjerum Nielsen A common airway pathogen in PCD is Pseudomonas aeruginosa (Pa), and the prevalence of this bacteria increases with age. In

Read More

PCDF Research Forum #6: Genotype/Phenotype Relationships in PCD

Primary Ciliary Dyskinesia: Longitudinal Study of Lung Disease by Ultrastructure Defect and Genotype Stephanie D. Davis et al. Link to study abstract Understanding and identifying the relationship between genotype (gene mutation) and phenotype (observable clinical traits) will be critical for advancing treatment of PCD. This paper by Davis, et al

Read More

PCDF Research Forum #5: Nocturnal Cough Analysis

Comparison of Nocturnal Cough Analysis in Healthy Subjects and in Patients with Cystic Fibrosis and Primary Ciliary Dyskinesia: A Prospective Observational Study. Radine A, Werner C, Raidt J, Dougherty GW, Kerschke L, Omran H, Grosse-Onnebrink J. This study set out to see if there is a difference in cough frequency between healthy subjects (HS), cystic fibrosis

Read More

NEWSLETTER SIGN-UP

Join our weekly newsletter for PCD updates.